Jane Street’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-122,500
| Closed | -$11.4M | – | 11466 |
|
|
2021
Q4 | $11.4M | Buy |
122,500
+82,700
| +208% | +$5.45M | ﹤0.01% | 1732 |
|
|
2021
Q3 | $2.37M | Buy |
39,800
+19,200
| +93% | +$1.13M | ﹤0.01% | 4132 |
|
|
2021
Q2 | $1.41M | Sell |
20,600
-46,100
| -69% | -$3.01M | ﹤0.01% | 5072 |
|
|
2021
Q1 | $4.63M | Buy |
66,700
+32,500
| +95% | +$2.5M | ﹤0.01% | 2515 |
|
|
2020
Q4 | $2.63M | Sell |
34,200
-149,200
| -81% | -$11.2M | ﹤0.01% | 3032 |
|
|
2020
Q3 | $13.7M | Buy |
183,400
+128,300
| +233% | +$8.55M | 0.01% | 988 |
|
|
2020
Q2 | $3.47M | Buy |
55,100
+47,400
| +616% | +$2.61M | ﹤0.01% | 2312 |
|
|
2020
Q1 | $323K | Buy |
+7,700
| New | +$353K | ﹤0.01% | 4119 |
|
|
2018
Q4 | – | Sell |
-21,700
| Closed | -$999K | – | 6014 |
|
|
2018
Q3 | $999K | Buy |
+21,700
| New | +$880K | ﹤0.01% | 2758 |
|
|
2018
Q2 | – | Sell |
-29,500
| Closed | -$1.17M | – | 5841 |
|
|
2018
Q1 | $1.17M | Buy |
29,500
+18,200
| +161% | +$708K | ﹤0.01% | 2466 |
|
|
2017
Q4 | $384K | Buy |
+11,300
| New | +$322K | ﹤0.01% | 3485 |
|
|
2017
Q2 | – | Sell |
-9,000
| Closed | -$131K | – | 5049 |
|
|
2017
Q1 | $131K | Buy |
+9,000
| New | +$133K | ﹤0.01% | 3941 |
|
|
2015
Q3 | – | Sell |
-1,640
| Closed | -$76K | – | 4332 |
|
|
2015
Q2 | $76K | Sell |
1,640
-1,550
| -49% | -$67.2K | ﹤0.01% | 3475 |
|
|
2015
Q1 | $139K | Buy |
+3,190
| New | +$148K | ﹤0.01% | 2960 |
|
Jane Street's ARNA Position: Q1 2022 in Review
Jane Street sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 14,334 shares — an estimated $1.33M sold.
Jane Street first reported a position in ARNA in Q2 2013 and held it in 23 quarters. The position peaked at $5.54M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Jane Street reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Jane Street sold 14,334 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.33M.
- Jane Street first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 23 quarters.
- Jane Street's Arena Pharmaceuticals Inc position peaked at $5.54M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.